Rectangular cymbal arrays for improved ultrasonic transdermal insulin delivery.
Circular cymbal ultrasound arrays have been shown to be effective in delivering therapeutic levels of insulin in rats, rabbits, and pigs. To improve delivery efficiency, a rectangular cymbal design was desired in order to achieve a broader spatial intensity field without increasing the size of the device or the spatial-peak temporal-peak intensity (I(SPTP)). With a similar intensity (50 mWcm(2)), the goal was to determine if the 3x1 rectangular cymbal array could perform significantly better than the 3x3 circular array for glucose reduction in hyperglycemic rabbits. Rabbit experiments were performed using three groups: nonsonicated control (n=3), ultrasound exposure using a circular cymbal array (n=3), and ultrasound exposure using a rectangular cymbal array (n=3). Rabbits were anesthetized and a water tight reservoir that held the insulin was fastened on the rabbit's thigh. At the beginning of the experiment and every 15 min for 90 min, the blood glucose level was determined. For comparison between individual rabbits, the absolute level is normalized by subtracting out the baseline in order to arrive at the change in glucose level. For the control group, the normalized glucose level increased (more hyperglycemic) to +80.0+/-28.8 mgdl (mean+/-SEM). Using the circular array, the glucose level decreased to -146.7+/-17.8 mgdl at 90 min. However, using the rectangular cymbal array, the glucose decreased faster and to a level of -200.8+/-5.9 mgdl after 90 min. These results indicated the feasibility of the rectangular cymbal array as an improved device for drug delivery.
Luis
Joseph
J
Graduate Program in Acoustics, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.
Park
Eun Joo
EJ
Meyer
Richard J
RJ
Smith
Nadine Barrie
NB
D000279:Administration, Cutaneous; D000818:Animals; D001786:Blood Glucose; D003198:Computer Simulation; D003921:Diabetes Mellitus, Experimental / Q000097:blood; D016503:Drug Delivery Systems / Q000295:instrumentation*; D004867:Equipment Design; D020342:Finite Element Analysis; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D009716:Numerical Analysis, Computer-Assisted; D015612:Phonophoresis / Q000295:instrumentation*; D011817:Rabbits; D013018:Sound Spectrography; D014159:Transducers
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin